Advanced Molecular PET Imaging and Tracer Development
March 26, 2026
What this project does
Supports research using emerging PET tracers to study neuroinflammation and neurotransmitter systems in ADRD.
Why it matters clinically
Novel PET tracers reveal disease mechanisms not visible on standard imaging and may identify new therapeutic targets.
Key activities
- Apply advanced PET tracers targeting neuroinflammation (e.g., TSPO, MAO-B) and neurotransmitter pathways (e.g., muscarinic function)
- Use arterial input functions and rigorous quantitative methods
- Support high-impact, externally funded PET imaging studies
What will be delivered
- Advanced PET imaging datasets
- Quantitative measures of inflammatory and neurotransmitter processes
Who this helps
- Translational researchers
- Clinicians interested in emerging imaging biomarkers